Caprolactam Chemicals Intrinsic Value
Caprolactam Chemicals (CAPRO) median intrinsic value is ₹32.94 from 9 valuation models (range ₹10–₹64), vs current price ₹49.82 — -33.9% downside (Trading Above Calculated Value), margin of safety -51.2%. For current market price and key ratios, visit Caprolactam Chemicals stock price NSE.
CAPRO Valuation Methods Summary — DCF, Graham Number & P/E
Caprolactam Chemicals intrinsic value across 9 models vs current price ₹49.82 — upside/downside and value range per method. Analyse CAPRO promoter holding to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹45.96 | ₹36.77 - ₹55.15 | -7.7% | EPS: ₹3.83, Sector P/E: 12x |
| Book Value Method | asset | ₹10.00 | ₹9.00 - ₹11.00 | -79.9% | Book Value/Share: ₹10.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹17.60 | ₹15.84 - ₹19.36 | -64.7% | Revenue/Share: ₹22.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹48.00 | ₹43.20 - ₹52.80 | -3.7% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹54.33 | ₹43.46 - ₹65.20 | +9.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹24.51 | ₹22.06 - ₹26.96 | -50.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹32.94 | ₹29.65 - ₹36.23 | -33.9% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹64.00 | ₹57.60 - ₹70.40 | +28.5% | ROE: 40.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹20.00 | ₹18.00 - ₹22.00 | -59.9% | EPS: ₹3.83, BVPS: ₹10.00 |
CAPRO Intrinsic Value vs Market Price — All Valuation Models
Caprolactam Chemicals fair value range ₹10–₹64 vs current market price ₹49.82 across 9 valuation models. Read Caprolactam Chemicals dividend payments for the complete payout history and dividend yield track record.
CAPRO Intrinsic Value Analysis — Undervalued or Overvalued?
Caprolactam Chemicals median intrinsic value ₹32.94, current price ₹49.82 — Trading Above Calculated Value by 33.9%, margin of safety -51.2%.
What is the intrinsic value of CAPRO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Caprolactam Chemicals (CAPRO) is ₹32.94 (median value). With the current market price of ₹49.82, this represents a -33.9% variance from our estimated fair value.
The valuation range spans from ₹10.00 to ₹64.00, indicating ₹10.00 - ₹64.00.
Is CAPRO undervalued or overvalued?
Based on our multi-method analysis, Caprolactam Chemicals (CAPRO) appears to be trading above calculated value by approximately 33.9%.
CAPRO Financial Health — Key Ratios vs Industry Benchmarks
Caprolactam Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 40.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 42.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.79x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CAPRO Cash Flow Quality — Operating & Free Cash Flow
Caprolactam Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹3 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |